Morgan Stanley’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Morgan Stanley’s Portfolio SKBI Stock Details SKBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-11,593	Closed	-$11K	–	7006
2015 Q3	$11K	Buy	11,593 +2,467	+27%	+$3.96K	﹤0.01%	6226
2015 Q2	$24K	Buy	9,126 +4,285	+89%	+$14.7K	﹤0.01%	6098
2015 Q1	$19K	Buy	+4,841	New	+$20.5K	﹤0.01%	6072
2014 Q4	–	Sell	-8,514	Closed	-$36K	–	6822
2014 Q3	$36K	Buy	+8,514	New	+$46.2K	﹤0.01%	5829

Other funds holding SKBI

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley's SKBI Position: Q4 2015 in Review

Morgan Stanley sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 11,593 shares — an estimated $11K sold.

Morgan Stanley first reported a position in SKBI in Q3 2014 and held it in 4 quarters. The position peaked at $36K in Q3 2014. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

Morgan Stanley reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
Morgan Stanley sold 11,593 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $11K.
Morgan Stanley first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q3 2014 and held it in 4 quarters.
Morgan Stanley's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $36K in Q3 2014.
1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on Morgan Stanley's 13F filing for Q4 2015, filed 9 Feb 2016.